A Study of Cebranopadol for Opioid Withdrawal Symptoms in Adults With Chronic Pain (clinicaltrials.gov) - Oct 24, 2026 - P2 | N=45 | Recruiting | Sponsor: Adneuris Therapeutics, Inc. | Not yet recruiting ➔ Recruiting
Enrollment open • Addiction (Opioid and Alcohol) • Pain • Substance Abuse
|